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Pluripotent stem cells provide a platform to interro-
gate control elements that function to generate all
cell types of the body. Despite their utility for
modeling development and disease, the relationship
of mouse and human pluripotent stem cell states to
one another remains largely undefined. We have
shown that mouse embryonic stem (ES) cells and
epiblast stem cells (EpiSCs) are distinct, pluripotent
states isolated from pre- and post-implantation
embryos respectively. Human ES cells are different
than mouse ES cells and share defining features
with EpiSCs, yet are derived from pre-implantation
human embryos. Here we show that EpiSCs can be
routinely derived from pre-implantation mouse
embryos. The preimplantation-derived EpiSCs ex-
hibit molecular features and functional properties
consistent with bona fide EpiSCs. These results
provide a simple method for isolating EpiSCs and
offer direct insight into the intrinsic and extrinsic
mechanisms that regulate the acquisition of distinct
pluripotent states.
INTRODUCTION
The invitroderivationofpluripotentstemcellsboth fromembryonic
and adult tissues holds tremendous promise for biology and
medicine. Until recently, access to the pluripotent state in vitro
was thought to be limited to the derivation of embryonic stem
(ES)cells frompreimplantationblastocystsand the reprogramming
of cells in the germ cell lineage. Reports of new pluripotent cell
types including induced pluripotent stem (iPS) cells and epiblast
stem cells (EpiSCs) provided a major impetus for recent studies
that evaluate the genetic and epigenetic mechanisms regulating
a cell’s acquisition of a pluripotent state (Brons et al., 2007; Taka-
hashi and Yamanaka, 2006; Tesar et al., 2007). However, we still
have only a primitive knowledge of the molecular mechanisms
controlling the acquisition and maintenance of pluripotency.318 Cell Stem Cell 8, 318–325, March 4, 2011 ª2011 Elsevier Inc.Equally unclear is how distinct pluripotent states relate to one
another as well as to cells in vivo in the developing embryo.
The archetypal pluripotent stem cells, mouse ES cells, are
routinely derived from preimplantation morula and blastocyst-
stage embryos (Brook and Gardner, 1997; Evans and Kaufman,
1981; Martin, 1981; Tesar, 2005). These cells can be expanded
indefinitely in culture while maintaining a stable genome and an
undifferentiated state. Mouse ES cells are remarkably able to
differentiate into all cell types of the embryo proper both in vitro
and in chimeras in vivo. Mouse ES cells, however, do not directly
recapitulate themolecular or signaling properties of their tissue of
origin and instead rely on somegenesandsignalingpathwaysnot
expressed or required in vivo in the blastocyst including genes
such as Nr3b2/Esrrb and Nr0b1/Dax1 and the LIF/Jak/Stat
signaling pathway (Chenoweth et al., 2010; Ivanova et al., 2006;
Niakan et al., 2006; Niwa et al., 1998, 2009; Wang et al., 2006;
Yu et al., 1998; Zhang et al., 2008). While mouse ES cells have
been widely employed in laboratories across the world, their
developmental origin and properties still remain unclear.
EpiSCs, on the other hand, are routinely isolated from the
epiblast of early postimplantation rodent embryos and recapitu-
late the defining properties of their in vivo tissue of origin (Bao
et al., 2009; Brons et al., 2007; Guo et al., 2009; Tesar et al.,
2007). Thesecells arepluripotent as theyare impressively capable
of differentiating into cell types of all three embryonic germ layers
as well as the germ lineage in vitro (Aoki et al., 2009; Hayashi and
Surani, 2009; Tesar et al., 2007; Vallier et al., 2009). EpiSCs canbe
expanded indefinitely in culturebeingmaintained in anundifferen-
tiated state by activin/Nodal and FGF signaling pathways (Brons
et al., 2007; Guo et al., 2009; Tesar et al., 2007). EpiSCs are regu-
lated by a stable pluripotent state that is distinct from that of
preimplantation-derived mouse ES cells.
Similar to mouse ES cells, human ES cells are derived from
preimplantation embryos (Thomson et al., 1998). Due to their
common origin, the pluripotent state of mouse and human ES
cellswasgenerally thought to be identical.Wepreviously showed
that human ES cells are distinct from mouse ES cells and, para-
doxically, share defining features with the postimplantation
epiblast state (Tesar et al., 2007). Unfortunately, the molecular
and cellular events that promote ES cell derivation remain poorly
described. It remains unclear why pluripotent cell lines isolated
from explanted mouse preimplantation embryos can attain
Figure 1. Intrinsic and Extrinsic Factors
Contribute to the Acquisition of Distinct
Pluripotent States from Preimplantation
Mouse Embryos
To derive pluripotent stem cells, preimplantation
blastocyst-stage embryos at E3.5 (shown as a
3D reconstruction immunostained for Oct3/4
[red] and Cdx2 [green]) were (A) explanted and
grown for 6 days under specific conditions (see
Experimental Procedures) at which point few cells
remained positive for the Oct3/4.
(B) Using passaging protocols described in this
manuscript, both ‘‘flat’’ and ‘‘domed’’ colony
morphologies were evident by day 16.
(C) ‘‘Domed’’ colonies gave rise to Oct3/4+ mouse
ES cell lines while (D) ‘‘flat’’ colonies produced
Oct3/4+ EpiSCs.
(E) The derivation efficiency for blastocyst-derived
mouse ES cells and EpiSCs was 28% and 26%,
respectively, in strain 129 but intrinsic genetic
elements present in other strains as well as
extrinsic modulation of signaling pathways altered
the efficiencies.
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explanted human preimplantation embryos attain a state similar
to that of the postimplantation epiblast.
To address these issues, we analyzed the impact of extrinsic
and intrinsic mechanisms on the acquisition of in vitro pluripotent
states when starting from preimplantation mouse embryos. Our
results show that both the mouse ES cell and EpiSC states can
be derived from the preimplantation blastocyst stage. The acqui-
sition of these states is dependent on extrinsic signals in the
culture medium as well as strain-intrinsic genetic elements.
RESULTS AND DISCUSSION
Epiblast Stem Cells Can Be Derived
from Preimplantation Mouse Embryos
The preimplantation blastocyst-stage embryo consists of two
overtly distinct tissues types, the trophectoderm and the innerCell Stem Cell 8, 318–3cell mass (ICM) (Gardner and Rossant,
1979; Rossant et al., 1978). The ICM
contains precursors that will generate
the epiblast, which, after implantation,
will differentiate into all of the somatic
and germ cell lineages of the embryo
proper (Lawson et al., 1991). The ICM of
the blastocyst has therefore served as
a source of cells for the in vitro derivation
of pluripotent ES cells frombothmice and
man (Evans and Kaufman, 1981; Martin,
1981; Thomson et al., 1998). Unexpect-
edly, blastocyst-derived mouse ES cells
exhibit a mix of molecular features
consistent with the epiblast precursors
in the ICM and early germ cell state
in vivo, while blastocyst-derived human
ES cells share defining features with the
postimplantation epiblast state. Theseresults suggest that the blastocyst may serve as a source for
multiple, distinct pluripotent states.
We modified the classical mouse ES cell derivation conditions
to test the ability of preimplantation mouse blastocysts to
directly generate EpiSCs, which are normally only derived from
postimplantation mouse embryos. Strain 129 blastocysts at
embryonic day 3.5 (E3.5) were explanted into separate wells
onto a feeder layer in K15F5 medium (see Experimental Proce-
dures), which was optimized to support both mouse ES-like
and epiblast-like pluripotent states (Figure 1A). Embryos
hatched from their zona pellucidae and attached to the feeder
layer overnight. The ICM was allowed to outgrow for 6 days, at
which time it was dissociated into small clusters and replated.
By day 16 two distinct colony types predominated in the
cultures: mouse ES-like (domed) or EpiSC-like (flat) (Figure 1B).
These colonies were easily distinguished from differentiating
extraembryonic cells such as trophectoderm or extraembryonic25, March 4, 2011 ª2011 Elsevier Inc. 319
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nies appeared to diverge early as conversion of morphology was
never observed. When domed colonies were picked and individ-
ually expanded by dissociation to a single cell suspension in
mouse ES cell growth conditions, they could be readily propa-
gated as mouse ES cell lines (Figure 1C). Flat colonies exposed
to the same treatments failed to expand as they did not typically
survive after single cell dissociation. We were, however, able to
propagate the flat colonies by employing conditions developed
for the growth of postimplantation-derived EpiSCs and human
ES cells (Figure 1D). In experiments where all media and feeder
cells were identical and carefully controlled, strain 129 blasto-
cysts (n = 42) yielded 12 mouse ES cell lines (28%) and 11 EpiSC
lines (26%) (Figure 1E). In only one instance were both an EpiSC
line and a mouse ES cell line derived from the same blastocyst
(shown in Figure 1B). These results show that both mouse ES-
like and epiblast-like pluripotent states can be derived from the
preimplantation blastocyst and maintained as stable cell lines.
Pre- and Postimplantation-Derived EpiSCs Share DNA
Methylation and Gene Expression Signatures
Previous work has elucidated gene expression and epigenetic
signatures that define and distinguish pluripotent states (Tesar
et al., 2007). Core pluripotency genes such as Oct3/4, Nanog,
and Sox2 are expressed in both mouse ES cell and EpiSC states
while other, nonoverlapping sets embody one or the other state.
While global geneexpressionhasproven to bea general indicator
of pluripotent state, metastable fluctuations in the mouse ES cell
pluripotent state often blur the boundaries (Furusawa et al., 2004;
Hayashi et al., 2008). For example,Dppa3, which is not expressed
in EpiSCs or human ES cells, is considered a defining marker of
the mouse ES cell state, but its expression is heterogeneous in
mouse ES cell cultures. It is thought that the Dppa3-negative
mouse ES cells aremore ‘‘epiblast-like’’ but have not been stably
committed to this transition since they readily revert to Dppa3-
positive. These metastable fluctuations highlight that gene
expression patterns are not sufficient to distinguish or define
the two pluripotent states. Previous studies have established
that global epigenetic differences exist between these twoplurip-
otent states (Hayashi et al., 2008; Tesar et al., 2007). Thesemarks
are stable and can be reliably used to ascertain cell state identity.
For example, Dppa3 hypermethylation is a defining mark of the
EpiSC state, where, regardless of transcriptional status, Dppa3
is hypomethylated in mouse ES cells (Hayashi et al., 2008).
We tested whether preimplantation-derived EpiSCs (E3.5)
shared molecular features with preimplantation-derived mouse
ES cells (E3.5) or postimplantation-derived EpiSCs (E5.5). Using
quantitative RT-PCR, we tested the expression of core pluripo-
tency genes as well as those previously described to define
the mouse ES cell or EpiSC state (Tesar et al., 2007). Preimplan-
tation-derived EpiSCs shared gene expression patterns consis-
tent with postimplantation-derived EpiSCs and not mouse ES
cells (Figure 2A). Using Agilent microarrays, we further analyzed
global gene expression patterns. Preimplantation-derived
EpiSCs showed high correlation with postimplantation-derived
EpiSCs and a clear distinction from mouse ES cells and other
blastocyst-derived stem cells such as FAB-SCs (Figure 2B). To
confirm these defining expression patterns, we analyzed DNA
methylation at the promoter region ofOct3/4, a core pluripotency320 Cell Stem Cell 8, 318–325, March 4, 2011 ª2011 Elsevier Inc.gene, andDppa3, whosemethylation pattern provides one of the
most reliable markers to differentiate between the mouse ES cell
and EpiSC states. Bisulfite pyrosequencing revealed that the
Oct3/4 promoter was hypomethylated in preimplantation-
derived EpiSCs consistent with all other known pluripotent cells
(Figure 2C). Dppa3 however was hypermethylated in both pre-
and postimplantation-derived EpiSCs while being hypomethy-
lated in mouse ES cells (Figure 2D). These results show that
preimplantation-derived EpiSCs share molecular features with
postimplantation-derived EpiSCs.
Pre- and Postimplantation-Derived EpiSCs Utilize
Similar Mechanisms to Regulate Pluripotency
and Differentiation
While the expression of specific genes provides a good indicator
of cellular state, analysis of the functional regulation of pluripo-
tency affords a better indicator. We first utilized a standard assay
of pluripotency by injecting preimplantation-derived EpiSCs
subcutaneously into immunocompromised mice. Preimplanta-
tion-derived EpiSCs readily formed teratomas consisting of a
mixture of cells representing all three classical germ layers.
Extensive differentiation was evident and included neural
rosettes, ganglion cells, gastrointestinal epithelium, hepato-
cytes, muscle, and adipocytes among others (Figure 3A and
Figure S1, available online). These results show that preimplan-
tation-derived EpiSCs are pluripotent.
We previously identified the regulation of activin/Nodal
signaling as a distinguishing characteristic of the mouse ES
cell and EpiSC states (Tesar et al., 2007). EpiSCs rely on
activin/Nodal signaling to maintain the pluripotent state and
when inhibited rapidly differentiate into the neurectodermal
lineage. In sharp contrast, mouse ES cells do not rely on acti-
vin/Nodal signaling to maintain pluripotency and its inhibition
does not result in differentiation. We tested the functional regu-
lation of activin/Nodal signaling in preimplantation-derived
EpiSCs. In response to treatment with a small molecule inhibitor
of Alk-4/5/7 (SB431542) to effectively block activin/Nodal
signaling, preimplantation-derived EpiSCs rapidly downregu-
lated core pluripotency genes, upregulated genes specific to
the neurectodermal lineage, and formed neural rosettes by day
4 (Figure 3B). This response was indistinguishable from that of
postimplantation-derived EpiSCs. Further analysis of global
gene expression changes in response to activin/Nodal inhibition
confirmed a high correlation of pre- and postimplantation-
derived EpiSC lines in both the undifferentiated and the differen-
tiating states (Figure 3C). These results show that preimplanta-
tion-derived EpiSCs are molecularly and functionally equivalent
to postimplantation-derived EpiSCs.
Intrinsic and Extrinsic Factors Regulate
the Acquisition of Distinct Pluripotent States
from Preimplantation Embryos
Previous studies demonstrated that the efficiency of deriving
mouse ES cells is dependent on genetic background (Brook
et al., 2003; Brook and Gardner, 1997; Gardner and Brook,
1997). Under standard conditions, one of the only mouse strains
to yield ES cell lines with an appreciable frequency is the inbred
strain 129. Interestingly, and probably not coincidentally, strain
129 is one of the only mouse strains to show a significant and
Figure 2. Pre- and Postimplantation-Derived EpiSCs Share Gene Expression and DNA Methylation Patterns that Are Distinct from Other
Pluripotent States
(A) Quantitative RT-PCR of preimplantation-derived EpiSCs (E3.5) showed gene expression patterns consistent with postimplantation-derived EpiSCs (E5.5) and
not preimplantation-derived mouse ES cells (E3.5). Values are presented as average ± SEM.
(B) Correlations of whole genomemicroarray data showed a strong correlation between pre- and postimplantation-derived EpiSCs and their clear distinction from
other pluripotent cells such as FAB-SCs and mouse ES cells.
(C and D) Bisulfite pyrosequencing of preimplantation-derived EpiSCs (E3.5) reveled hypermethylation of CpGs in the (C) Dppa3 promoter region and hypome-
thylation in (D) Oct3/4 promoter region. The location of analyzed CpGs is indicated in red. Values are presented as average ± SEM.
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vens and Little, 1954). Most other mouse strains are refractory to
both the acquisition of the pluripotent mouse ES cell state
in vitro under standard conditions and the acquisition of pluripo-
tent tumors within the germline. Recently, mouse ES cells were
reproducibly derived for the first time from the prototypical
‘‘nonpermissive’’ nonobese diabetic (NOD) strain blastocysts
and through iPS cell-based reprogramming from fibroblasts
(Hanna et al., 2009; Nichols et al., 2009). While providing an
exciting opportunity to utilize the power of mouse ES cells (gene
targeting,chimerageneration, etc.) in thiswidelyemployedmodel,
these new NOD mouse ES cells proved to be highly unstable inthat they required continual stimulation of c-myc or Klf4 through
inducible transgene overexpression or other exogenous means.
Conversely, the isolation of EpiSCs from postimplantation
mouse embryos is not dependent on strain-specific modulators.
EpiSCs have been derived from a plethora of mouse strains
under standard conditions. We tested the ability to isolate
EpiSCs from preimplantation embryos of strains that do not
readily yield mouse ES cell lines such as NOD and the consomic
strain 129-Chr18MOLF in which theMOLF/EiJ strain chromosome
18 homozygously replaced the strain 129 chromosome 18 on an
inbred 129 background (Anderson et al., 2009). Interestingly,
while failing to yield mouse ES cell lines at any appreciableCell Stem Cell 8, 318–325, March 4, 2011 ª2011 Elsevier Inc. 321
Figure 3. Pre- and Postimplantation-
Derived EpiSCs Utilize Similar and Develop-
mentally Relevant Mechanisms to Regulate
Pluripotency and Differentiation
(A) Preimplantation-derived EpiSCs are pluripo-
tent as evidenced by hematoxylin- and eosin-
stained histological sections of teratomas.
Examples of specific cell types are denoted with
an arrow. Additional images are found in Figure S1.
Both preimplantation (E3.5)- and postimplantation
(E5.5)-derived EpiSCs exited pluripotency and
differentiated into neural rosettes in response to
Alk-4/5/7 inhibition while mouse ES cells main-
tained their pluripotency as evidenced by (B)
morphology and (C) hierarchical cluster analysis
of whole-genome microarray data of treated and
untreated samples.
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Preimplantation Epiblast Stem Cellsfrequency, NOD and 129-Chr18MOLF blastocysts yielded EpiSCs
at a frequency equivalent to strain 129,25% (Figure 1E). These
results show that strain-specific genetic elements restricting
access to the mouse ES cell pluripotent state do not impact
access to the EpiSC state and suggest that intrinsic genetic
elements in a limited number of strains such as 129 modulate
entry or stabilization of the mouse ES cell state.
External signals could also modulate access to distinct plurip-
otent states. In fact, recent work has shown that inhibition of both
MAPK and GSK3b (referred to as 2i) and activation of the Jak/
Stat3 pathway via LIF can enhance the efficiency of mouse ES
cell line derivation and allow for derivation in some previously
nonpermissive strains (Ying et al., 2008). We tested whether inhi-
bition of Jak/Stat signaling, a pathway required for mouse ES
cells but not EpiSCs, would alter the ability to isolate either
pluripotent state. Inhibition of Jak/Stat signaling with a small
molecule inhibitor of Jak resulted in a failure of strain 129 blasto-322 Cell Stem Cell 8, 318–325, March 4, 2011 ª2011 Elsevier Inc.cysts to yield mouse ES cell lines while
EpiSC lines could be readily derived (Fig-
ure 1E). These results show that extrinsic
cues can modulate the acquisition of
distinct pluripotent states. Additionally,
these results raise interesting questions
about the lineage relationship of distinct
pluripotent cell types and renews interest
in the possibility that mouse ES cells
could be of germ cell origin (Zwaka and
Thomson, 2005) (see model in Figure S2).
Understanding of both intrinsic and
extrinsic modifiers will provide critical
insight into the acquisition of pluripotency
(see Figure 4). In fact, a recent study has
shown that simple modulation of the
extrinsic signaling conditions determines
whether overexpression of Oct3/4,
Sox2, Klf4, and c-myc gives rise to either
iPS cells or induced EpiSCs (iEpiSCs)
(Han et al., 2011). Further knowledge
should advance efforts to create defined
pluripotent cell lines, whether from
embryos, somatic cells, or germ cells,and reliably control their differentiation to functional derivatives
for laboratory and clinical use.
EXPERIMENTAL PROCEDURES
Embryos
Timed natural matings were used for all experiments. Twelve hours from the
middle of the dark period was termed embryonic day 0.5 (E0.5). Mouse embry-
onic fibroblasts (MEFs) were obtained from E13.5 fetuses from the CF1 strain
(Charles River). Preimplantation blastocyst-stage embryos from 129S1/SvImJ
(Jackson Laboratories), 129-Chr18MOLF (Anderson et al., 2009), or nonobese
diabetic (NOD) strains were flushed from the uterine horns on E3.5 into FHM
HEPES-buffered medium (Millipore).
Derivation of Mouse ES Cells and EpiSCs from Blastocysts
Individual blastocysts were explanted into 1.9 cm2 wells containing g-irradiated
MEFs preincubated with K15F5 medium, which consisted of Knockout DMEM
(Invitrogen) supplemented with 15% Knockout Serum Replacement (KSR; Invi-
trogen), 5% ES cell-qualified fetal bovine serum (FBS; GIBCO lot: 52207), 2 mM
Figure 4. Acquisition of Distinct Pluripotent
States
Summary diagram depicting the multiple avenues
that have provided access to the two pluripotent
states (mouse ES-like and epiblast-like) and high-
lighting the contribution of this manuscript to the
field. See also Figure S2.
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Preimplantation Epiblast Stem CellsGlutamax (Invitrogen), 13 nonessential amino acids (Invitrogen), and 0.1 mM
2-mercaptoethanol (Sigma) with no additional growth factor additives. After
5–6 days the ICMs had reached a suitable size and were picked off the plate
with a pulled glass pipette and incubated for 5 min at room temperature in an
8 ml drop of 0.25% trypsin-EDTA. The ICMs were partially dissociated individu-
ally with a pulled glass pipette. Caution was taken not to produce a completely
single-cell suspension. The partial dissociates were plated individually into
a 1.9 cm2 well containing a feeder layer of irradiated MEFs and cultured for an
additional 6 days in K15F5 medium without additional growth factor additives.
At this point each culture was passaged by a brief exposure (2–3 min) to
0.25% trypsin/EDTA, inactivation of trypsin with FBS-containing MEF medium,
gentle tritration to prevent complete single-cell dissociation of any pluripotent
clusters, and plating into a 9.6 cm2 well containing feeders in K15F5 medium.
Morphologically distinct mouse ES cell and/or EpiSC colonies became evident
over the next 4–8 days (16–20 total days from initial blastocyst explants). These
colony types were separately expanded in medium designed to support either
mouse ES cells or EpiSCs. Mouse ES cell colonies were individually picked
from the plate and dissociated to a single-cell suspension in 8 ml drops of
trypsin/EDTA andplated into 1.9 cm2wells containing feeders in K15F5medium
supplementedwith 103 units/ml leukemia inhibitory factor (LIF; Millipore). EpiSC
colonies weremanually dissociated into small clusters using a glass needle and
plated into 1.9 cm2 wells containing feeders in EpiSC cell medium consisting of
Knockout DMEMsupplemented with 20%KSR, 2mMglutamax, 13 nonessen-
tial aminoacids, 0.1mM2-mercaptoethanol, and10ng/mlFGF2 (R&DSystems).
For experiments testing the impact of Jak inhibition on pluripotent stem cell
derivation, Jak Inhibitor I (Calbiochem) was provided to the cultures starting at
day 0 (blastocyst explant) and added daily until colony picking (day 16–20).
Cell Culture
Mouse ES cells were passaged every third day as a single-cell suspension
using 0.25% trypsin/EDTA and seeded at 3.0 3 104 cells/cm2 for routine
culture. EpiSCs were passaged every third day using 1.5 mg/ml collagenaseCell Stem Cell 8, 318–3type IV (Invitrogen) and trituration into small clumps
of 10–100 cells. MEFs were maintained with
DMEM supplemented with 10% FBS, 2 mM gluta-
max, 13 nonessential amino acids, and 0.1 mM
2-mercaptoethanol. MEFs were irradiated with
30–60 gray and seeded as feeders at a density of
5.0 3 104 cells/cm2. All cells were grown on Nun-
clon D-treated dishes or multiwell plates (Fisher
Scientific) coated for 2 hr at 37C with 0.1% (w/v)
porcine gelatin (Sigma). Antibiotics at concentra-
tions of 50 units/ml and 50 mg/ml for penicillin and
streptomycin, respectively, were used only for
primary explants of MEFs and blastocysts.
Small Molecule Treatment
SB431542 wasmaintained as a 20mM stock solu-
tion in DMSO (vehicle) and was provided at 20 mM
to the cultures at the time of plating and every day
thereafter with the media change. JAK inhibitor I
(Calbiochem) was maintained as a 10 mM stock
in DMSO and provided at 0.6 mM every day.
Immunostaining
Cells were prepared for immunostaining by fixa-
tion in 4% paraformaldehyde (Electron Micros-
copy Sciences) for 15 min and subsequentpermeabilization for 10minwith 0.2%Triton-X in PBS. Cells were then blocked
for nonspecific bindingwith 10%normal goat or donkey serum (Abcam) in PBS
for 1–2 hr at room temperature. Primary antibodies were diluted in blocking
solution and incubated with the samples overnight at 4C. Samples were
rinsed with PBS and incubated with the appropriate fluorescently labeled
Alexa secondary antibodies (Invitrogen, 1:500) for 1 hr at room temperature.
Primary antibodies used were as follows: mouse monoclonal IgG2b Oct3/4
(C-10; Santa Cruz, 1:400), mousemonoclonal IgG1Cdx2 (CDX2-88; Biogenex,
1:50), and rabbit polyclonal Blimp1 (kindly provided by Reuben Tooze, Leeds,
UK, 1:100). Nuclei were visualized with DAPI (Sigma, 1 mg/ml).
Bisulphite Pyrosequencing
Genomic DNA was isolated from preimplantation-derived mES cells, preim-
plantation-derived EpiSCs, and postimplantation-derived EpiSCs after their
separation from the feeders. Bisulfite modification of 500 ng of genomic
DNA was done using the EZ DNA Methylation kit (Zymo Research). Bisulfite
converted DNA was used with gene-specific primers (Epigendx) to amplify
promoter regions of Pou5f1 (ASY585; 11 CpGs sites analyzed) and Dppa3
(ADS1399; 6 CpG sites analyzed) using HotStar Taq polymerase (QIAGEN).
Methylation of the amplified regions was quantified by pyrosequencing using
a PyroMark Q96 ID platform (QIAGEN). Unmethylated and in vitro methylated
DNA (Epigendx) served as controls. Percentage of methylation was deter-
mined by the percentage of C to T conversion at the analyzed CpG sites.
RNA Preparation and qRT-PCR
Total RNA was prepared using TRIzol (Invitrogen) and samples were treated
with DNase (turbo DNA-free, Applied Biosystems). RNA (400 ng) was reverse
transcribed using Superscript III (Invitrogen) with random primers. Real-Time
PCRwasperformedusing8ngofcDNAaccording to themanufacturer’sprotocol
using the Applied Biosystems (ABI) 7300 Real-Time PCR System with the ABI
TaqMan Gene Expression Master Mix and Taqman preoptimized gene expres-
sion assays: Zfp42 (Mm01194090_g1), Dppa3 (Mm01184198_g1), Oct3/425, March 4, 2011 ª2011 Elsevier Inc. 323
Cell Stem Cell
Preimplantation Epiblast Stem Cells(Mm00658129_gH), Nanog (Mm02019550_s1), Cer1 (Mm00515474_m1), and
FGF5 (Mm00438919_m1). Gapdh (Mm99999915_g1) served as an endogenous
control for normalization.
Teratomas
Blastocyst-derived EpiSCs were tested for their ability to form teratomas in
immunocompromised hosts. Colonies were triturated to produce small cell
clusters and cells were resuspended in Knockout DMEM supplemented with
30% growth factor reduced Matrigel (BD Biosciences) at a concentration of
1 3 107 cells/ml . One hundred microliters of cell suspension (1 3 106 cells)
was injected subcutaneously into the left flank of female, athymic NCr-nu/nu
mice (bred in house; n = 4 per line). Tumors were allowed to develop for
4–8 weeks at which time they were removed and fixed in 4% paraformalde-
hyde for 36 hr. Teratomas were embedded in paraffin, sectioned, and stained
with hematoxylin and eosin (H&E).
Expression Microarrays
RNA samples were isolated and analyzed using whole-genome Agilent 4 3
44K Mouse arrays (G4122F) as described previously (Tesar et al., 2007).
Publically available samples were downloaded from GEO (NCBI) and used
as comparators in Figures 2. Hierarchical clustering and correlation analysis
of samples was performed using Genespring software.
ACCESSION NUMBERS
All data are available on the NCBI Gene Expression Omnibus website through
GEO Series accession GSE26814.
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